BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 28530684)

  • 1. Tackling HIV and AIDS: contributions by non-human primate models.
    Van Rompay KKA
    Lab Anim (NY); 2017 May; 46(6):259-270. PubMed ID: 28530684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of nonhuman primate models of HIV infection for the evaluation of antiviral strategies.
    Van Rompay KK
    AIDS Res Hum Retroviruses; 2012 Jan; 28(1):16-35. PubMed ID: 21902451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superior Efficacy of a Human Immunodeficiency Virus Vaccine Combined with Antiretroviral Prevention in Simian-Human Immunodeficiency Virus-Challenged Nonhuman Primates.
    Le Grand R; Dereuddre-Bosquet N; Dispinseri S; Gosse L; Desjardins D; Shen X; Tolazzi M; Ochsenbauer C; Saidi H; Tomaras G; Prague M; Barnett SW; Thiebaut R; Cope A; Scarlatti G; Shattock RJ
    J Virol; 2016 Jun; 90(11):5315-5328. PubMed ID: 27009957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The roles of nonhuman primates in the preclinical evaluation of candidate AIDS vaccines.
    Staprans SI; Feinberg MB
    Expert Rev Vaccines; 2004 Aug; 3(4 Suppl):S5-32. PubMed ID: 15285703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonhuman primate models for HIV vaccine development.
    Letvin NL
    Immunodefic Rev; 1992; 3(3):247-60. PubMed ID: 1510838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonhuman primate models for HIV/AIDS vaccine development.
    Sui Y; Gordon S; Franchini G; Berzofsky JA
    Curr Protoc Immunol; 2013 Oct; 102():12.14.1-12.14.30. PubMed ID: 24510515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiretroviral drug studies in nonhuman primates: a valid animal model for innovative drug efficacy and pathogenesis experiments.
    Van Rompay KK
    AIDS Rev; 2005; 7(2):67-83. PubMed ID: 16092501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AIDS preclinical vaccine development: biennial survey of HIV, SIV, and SHIV challenge studies in vaccinated nonhuman primates.
    Warren JT; Levinson MA
    J Med Primatol; 1999; 28(4-5):249-73. PubMed ID: 10593492
    [No Abstract]   [Full Text] [Related]  

  • 9. Non-human primates in HIV research: Achievements, limits and alternatives.
    Garcia-Tellez T; Huot N; Ploquin MJ; Rascle P; Jacquelin B; Müller-Trutwin M
    Infect Genet Evol; 2016 Dec; 46():324-332. PubMed ID: 27469027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The levels of DNGR-1 and its ligand-bearing cells were altered after human and simian immunodeficiency virus infection.
    Yao WR; Li D; Yu L; Wang FJ; Xing H; Yang GB
    Immunol Res; 2017 Aug; 65(4):869-879. PubMed ID: 28478499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral immunity to HIV, SIV, and SHIV.
    Haigwood NL; Zolla-Pazner S
    AIDS; 1998; 12 Suppl A():S121-32. PubMed ID: 9632993
    [No Abstract]   [Full Text] [Related]  

  • 12. AIDS vaccine research. A new goal: preventing disease, not infection.
    Cohen J
    Science; 1993 Dec; 262(5141):1820-1. PubMed ID: 8266069
    [No Abstract]   [Full Text] [Related]  

  • 13. Nonhuman primate models for HIV cure research.
    Apetrei C; Pandrea I; Mellors JW
    PLoS Pathog; 2012; 8(8):e1002892. PubMed ID: 22956905
    [No Abstract]   [Full Text] [Related]  

  • 14. Prospects for vaccine protection against HIV-1 infection and AIDS.
    Letvin NL; Barouch DH; Montefiori DC
    Annu Rev Immunol; 2002; 20():73-99. PubMed ID: 11861598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into the Impact of CD8
    Rife Magalis B; Nolan DJ; Autissier P; Burdo TH; Williams KC; Salemi M
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Animal models for HIV/AIDS research.
    Hatziioannou T; Evans DT
    Nat Rev Microbiol; 2012 Dec; 10(12):852-67. PubMed ID: 23154262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of antiretrovirals in animal models of HIV infection.
    Van Rompay KK
    Antiviral Res; 2010 Jan; 85(1):159-75. PubMed ID: 19622373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationally Designed Vaccines Targeting the V2 Region of HIV-1 gp120 Induce a Focused, Cross-Clade-Reactive, Biologically Functional Antibody Response.
    Zolla-Pazner S; Powell R; Yahyaei S; Williams C; Jiang X; Li W; Lu S; Wang S; Upadhyay C; Hioe CE; Totrov M; Kong X
    J Virol; 2016 Dec; 90(24):10993-11006. PubMed ID: 27630234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of primate models for AIDS.
    Haigwood NL
    AIDS Rev; 2004; 6(4):187-98. PubMed ID: 15700617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards an AIDS vaccine: the role of primate models.
    Nathanson N
    Int J STD AIDS; 1998; 9 Suppl 1():3-7. PubMed ID: 9874107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.